ESTIMATION OF THEOPHYLLINE ABSORPTION RATE BY MEANS OF THE WAGNER-NELSON EQUATION

被引：15

作者：

WAGNER, JG ^{[1
]}

机构：

[1] UNIV MICHIGAN,SCH MED,UPJOHN CTR CLIN PHARMACOL,ANN ARBOR,MI 48109

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1986年 / 78卷 / 04期

关键词：

D O I：

10.1016/0091-6749(86)90046-1

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：681 / 688

页数：8

共 15 条

[1]

CABANNA BE, 1980, BETTER SAFETY DRUGS, P301

[2] THEO-DUR AND THEO-DUR SPRINKLE - CONTROLLED-RELEASE DELIVERY SYSTEMS FOR THEOPHYLLINE [J].

GONZALEZ, MA ;

GOLUB, AL .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1983, 9 (07) :1379-1396

[3]

HEIMLICH BN, 1978, 25TH NAT M AC PHARM, V8, P79

[4] INTRAINDIVIDUAL VARIABILITY IN THEOPHYLLINE PHARMACOKINETICS - STATISTICAL VERIFICATION IN 39 OF 60 HEALTHY-YOUNG ADULTS [J].

UPTON, RA ;

THIERCELIN, JF ;

GUENTERT, TW ;

WALLACE, SM ;

POWELL, JR ;

SANSOM, L ;

RIEGELMAN, S .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (02) :123-134

[5]

Wagner J.G., 1984, PHARMACOKINETICS MOD, P173

[6] MODIFIED WAGNER-NELSON ABSORPTION EQUATIONS FOR MULTIPLE-DOSE REGIMENS [J].

WAGNER, JG .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (05) :578-579

[7] THE WAGNER NELSON METHOD APPLIED TO A MULTICOMPARTMENT MODEL WITH ZERO ORDER INPUT [J].

WAGNER, JG .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1983, 4 (04) :359-373

[8] THEOPHYLLINE POOLED MICHAELIS-MENTEN PARAMETERS (VMAX AND KM) AND IMPLICATIONS [J].

WAGNER, JG .

CLINICAL PHARMACOKINETICS, 1985, 10 (05) :432-442

[9] APPLICATION OF WAGNER-NELSON ABSORPTION METHOD TO 2-COMPARTMENT OPEN MODEL [J].

WAGNER, JG .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (06) :469-486

[10] EFFECT OF USING AN INCORRECT ELIMINATION RATE-CONSTANT IN APPLICATION OF THE WAGNER-NELSON METHOD TO THEOPHYLLINE DATA IN CASES OF ZERO ORDER ABSORPTION [J].

WAGNER, JG .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1984, 5 (01) :75-83

← 1 2 →